Global Nucleic Acid Blood Screening Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Nucleic Acid Blood Screening: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Nucleic Acid Blood Screening Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Blood Screening Equipment
1.2.3 blood Screening Reagents
1.3 Market Segmentation by Application
1.3.1 Global Nucleic Acid Blood Screening Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Blood Center
1.3.3 Central Blood Station
1.3.4 Central Blood Bank
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nucleic Acid Blood Screening Revenue Estimates and Forecasts 2020-2031
2.2 Global Nucleic Acid Blood Screening Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Nucleic Acid Blood Screening Sales Estimates and Forecasts 2020-2031
2.4 Global Nucleic Acid Blood Screening Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Nucleic Acid Blood Screening Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Nucleic Acid Blood Screening Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Blood Screening Equipment Market Size by Manufacturers
3.5.2 blood Screening Reagents Market Size by Manufacturers
3.6 Global Nucleic Acid Blood Screening Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Nucleic Acid Blood Screening Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Nucleic Acid Blood Screening Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Nucleic Acid Blood Screening Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Nucleic Acid Blood Screening Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Nucleic Acid Blood Screening Sales and Revenue by Type (2020-2031)
6.4 North America Nucleic Acid Blood Screening Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Nucleic Acid Blood Screening Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Nucleic Acid Blood Screening Sales and Revenue by Type (2020-2031)
7.4 Europe Nucleic Acid Blood Screening Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Nucleic Acid Blood Screening Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Nucleic Acid Blood Screening Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Nucleic Acid Blood Screening Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Nucleic Acid Blood Screening Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Nucleic Acid Blood Screening Sales and Revenue by Type (2020-2031)
9.4 Central and South America Nucleic Acid Blood Screening Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Nucleic Acid Blood Screening Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Nucleic Acid Blood Screening Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Nucleic Acid Blood Screening Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Nucleic Acid Blood Screening Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Business Overview
11.1.3 Roche Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.1.4 Roche Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Roche Nucleic Acid Blood Screening Sales by Product in 2024
11.1.6 Roche Nucleic Acid Blood Screening Sales by Application in 2024
11.1.7 Roche Nucleic Acid Blood Screening Sales by Geographic Area in 2024
11.1.8 Roche Nucleic Acid Blood Screening SWOT Analysis
11.1.9 Roche Recent Developments
11.2 Grifols Diagnostic Solutions
11.2.1 Grifols Diagnostic Solutions Corporation Information
11.2.2 Grifols Diagnostic Solutions Business Overview
11.2.3 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.2.4 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales by Product in 2024
11.2.6 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales by Application in 2024
11.2.7 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales by Geographic Area in 2024
11.2.8 Grifols Diagnostic Solutions Nucleic Acid Blood Screening SWOT Analysis
11.2.9 Grifols Diagnostic Solutions Recent Developments
11.3 KHB
11.3.1 KHB Corporation Information
11.3.2 KHB Business Overview
11.3.3 KHB Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.3.4 KHB Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 KHB Nucleic Acid Blood Screening Sales by Product in 2024
11.3.6 KHB Nucleic Acid Blood Screening Sales by Application in 2024
11.3.7 KHB Nucleic Acid Blood Screening Sales by Geographic Area in 2024
11.3.8 KHB Nucleic Acid Blood Screening SWOT Analysis
11.3.9 KHB Recent Developments
11.4 Bacme Bio
11.4.1 Bacme Bio Corporation Information
11.4.2 Bacme Bio Business Overview
11.4.3 Bacme Bio Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.4.4 Bacme Bio Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Bacme Bio Nucleic Acid Blood Screening Sales by Product in 2024
11.4.6 Bacme Bio Nucleic Acid Blood Screening Sales by Application in 2024
11.4.7 Bacme Bio Nucleic Acid Blood Screening Sales by Geographic Area in 2024
11.4.8 Bacme Bio Nucleic Acid Blood Screening SWOT Analysis
11.4.9 Bacme Bio Recent Developments
11.5 Daan Gene
11.5.1 Daan Gene Corporation Information
11.5.2 Daan Gene Business Overview
11.5.3 Daan Gene Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.5.4 Daan Gene Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Daan Gene Nucleic Acid Blood Screening Sales by Product in 2024
11.5.6 Daan Gene Nucleic Acid Blood Screening Sales by Application in 2024
11.5.7 Daan Gene Nucleic Acid Blood Screening Sales by Geographic Area in 2024
11.5.8 Daan Gene Nucleic Acid Blood Screening SWOT Analysis
11.5.9 Daan Gene Recent Developments
11.6 Wantai Biotechnology
11.6.1 Wantai Biotechnology Corporation Information
11.6.2 Wantai Biotechnology Business Overview
11.6.3 Wantai Biotechnology Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.6.4 Wantai Biotechnology Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Wantai Biotechnology Recent Developments
11.7 Sansure Biotech
11.7.1 Sansure Biotech Corporation Information
11.7.2 Sansure Biotech Business Overview
11.7.3 Sansure Biotech Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.7.4 Sansure Biotech Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Sansure Biotech Recent Developments
11.8 Zhuhai Livzon Reagents
11.8.1 Zhuhai Livzon Reagents Corporation Information
11.8.2 Zhuhai Livzon Reagents Business Overview
11.8.3 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.8.4 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Zhuhai Livzon Reagents Recent Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Corporation Information
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.9.4 Bio-Rad Laboratories Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Bio-Rad Laboratories Recent Developments
11.10 Horiba
11.10.1 Horiba Corporation Information
11.10.2 Horiba Business Overview
11.10.3 Horiba Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.10.4 Horiba Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Horiba Recent Developments
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Corporation Information
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.11.4 Thermo Fisher Scientific Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Thermo Fisher Scientific Recent Developments
11.12 bioMerieux
11.12.1 bioMerieux Corporation Information
11.12.2 bioMerieux Business Overview
11.12.3 bioMerieux Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.12.4 bioMerieux Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 bioMerieux Recent Developments
11.13 Danaher
11.13.1 Danaher Corporation Information
11.13.2 Danaher Business Overview
11.13.3 Danaher Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.13.4 Danaher Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Danaher Recent Developments
11.14 Abbott
11.14.1 Abbott Corporation Information
11.14.2 Abbott Business Overview
11.14.3 Abbott Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.14.4 Abbott Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Abbott Recent Developments
11.15 BD
11.15.1 BD Corporation Information
11.15.2 BD Business Overview
11.15.3 BD Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.15.4 BD Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 BD Recent Developments
11.16 Mindray
11.16.1 Mindray Corporation Information
11.16.2 Mindray Business Overview
11.16.3 Mindray Nucleic Acid Blood Screening Product Models, Descriptions and Specifications
11.16.4 Mindray Nucleic Acid Blood Screening Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Mindray Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Nucleic Acid Blood Screening Industry Chain
12.2 Nucleic Acid Blood Screening Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Nucleic Acid Blood Screening Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Nucleic Acid Blood Screening Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Nucleic Acid Blood Screening Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Nucleic Acid Blood Screening Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Nucleic Acid Blood Screening Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Nucleic Acid Blood Screening Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Nucleic Acid Blood Screening Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Nucleic Acid Blood Screening Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Nucleic Acid Blood Screening Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Nucleic Acid Blood Screening Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Nucleic Acid Blood Screening Sales by Region (2020-2025) & (K Units)
Table 8. Global Nucleic Acid Blood Screening Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Nucleic Acid Blood Screening Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Nucleic Acid Blood Screening Sales Share by Manufacturers (2020-2025)
Table 12. Global Nucleic Acid Blood Screening Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Nucleic Acid Blood Screening Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Nucleic Acid Blood Screening by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Blood Screening as of 2024)
Table 16. Global Nucleic Acid Blood Screening Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Nucleic Acid Blood Screening Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Nucleic Acid Blood Screening Manufacturing Base and Headquarters
Table 19. Global Nucleic Acid Blood Screening Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Nucleic Acid Blood Screening Sales by Type (2020-2025) & (K Units)
Table 23. Global Nucleic Acid Blood Screening Sales by Type (2026-2031) & (K Units)
Table 24. Global Nucleic Acid Blood Screening Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Nucleic Acid Blood Screening Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Nucleic Acid Blood Screening ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Nucleic Acid Blood Screening Sales by Application (2020-2025) & (K Units)
Table 29. Global Nucleic Acid Blood Screening Sales by Application (2026-2031) & (K Units)
Table 30. Nucleic Acid Blood Screening High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Nucleic Acid Blood Screening Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Nucleic Acid Blood Screening Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Nucleic Acid Blood Screening ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Nucleic Acid Blood Screening Growth Accelerators and Market Barriers
Table 37. North America Nucleic Acid Blood Screening Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Nucleic Acid Blood Screening Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Nucleic Acid Blood Screening Growth Accelerators and Market Barriers
Table 40. Europe Nucleic Acid Blood Screening Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Nucleic Acid Blood Screening Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Nucleic Acid Blood Screening Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Nucleic Acid Blood Screening Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Nucleic Acid Blood Screening Growth Accelerators and Market Barriers
Table 45. Southeast Asia Nucleic Acid Blood Screening Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Nucleic Acid Blood Screening Investment Opportunities and Key Challenges
Table 47. Central and South America Nucleic Acid Blood Screening Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Nucleic Acid Blood Screening Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Nucleic Acid Blood Screening Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Roche Corporation Information
Table 51. Roche Description and Major Businesses
Table 52. Roche Product Models, Descriptions and Specifications
Table 53. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Roche Sales Value Proportion by Product in 2024
Table 55. Roche Sales Value Proportion by Application in 2024
Table 56. Roche Sales Value Proportion by Geographic Area in 2024
Table 57. Roche Nucleic Acid Blood Screening SWOT Analysis
Table 58. Roche Recent Developments
Table 59. Grifols Diagnostic Solutions Corporation Information
Table 60. Grifols Diagnostic Solutions Description and Major Businesses
Table 61. Grifols Diagnostic Solutions Product Models, Descriptions and Specifications
Table 62. Grifols Diagnostic Solutions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Grifols Diagnostic Solutions Sales Value Proportion by Product in 2024
Table 64. Grifols Diagnostic Solutions Sales Value Proportion by Application in 2024
Table 65. Grifols Diagnostic Solutions Sales Value Proportion by Geographic Area in 2024
Table 66. Grifols Diagnostic Solutions Nucleic Acid Blood Screening SWOT Analysis
Table 67. Grifols Diagnostic Solutions Recent Developments
Table 68. KHB Corporation Information
Table 69. KHB Description and Major Businesses
Table 70. KHB Product Models, Descriptions and Specifications
Table 71. KHB Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. KHB Sales Value Proportion by Product in 2024
Table 73. KHB Sales Value Proportion by Application in 2024
Table 74. KHB Sales Value Proportion by Geographic Area in 2024
Table 75. KHB Nucleic Acid Blood Screening SWOT Analysis
Table 76. KHB Recent Developments
Table 77. Bacme Bio Corporation Information
Table 78. Bacme Bio Description and Major Businesses
Table 79. Bacme Bio Product Models, Descriptions and Specifications
Table 80. Bacme Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Bacme Bio Sales Value Proportion by Product in 2024
Table 82. Bacme Bio Sales Value Proportion by Application in 2024
Table 83. Bacme Bio Sales Value Proportion by Geographic Area in 2024
Table 84. Bacme Bio Nucleic Acid Blood Screening SWOT Analysis
Table 85. Bacme Bio Recent Developments
Table 86. Daan Gene Corporation Information
Table 87. Daan Gene Description and Major Businesses
Table 88. Daan Gene Product Models, Descriptions and Specifications
Table 89. Daan Gene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Daan Gene Sales Value Proportion by Product in 2024
Table 91. Daan Gene Sales Value Proportion by Application in 2024
Table 92. Daan Gene Sales Value Proportion by Geographic Area in 2024
Table 93. Daan Gene Nucleic Acid Blood Screening SWOT Analysis
Table 94. Daan Gene Recent Developments
Table 95. Wantai Biotechnology Corporation Information
Table 96. Wantai Biotechnology Description and Major Businesses
Table 97. Wantai Biotechnology Product Models, Descriptions and Specifications
Table 98. Wantai Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Wantai Biotechnology Recent Developments
Table 100. Sansure Biotech Corporation Information
Table 101. Sansure Biotech Description and Major Businesses
Table 102. Sansure Biotech Product Models, Descriptions and Specifications
Table 103. Sansure Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Sansure Biotech Recent Developments
Table 105. Zhuhai Livzon Reagents Corporation Information
Table 106. Zhuhai Livzon Reagents Description and Major Businesses
Table 107. Zhuhai Livzon Reagents Product Models, Descriptions and Specifications
Table 108. Zhuhai Livzon Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Zhuhai Livzon Reagents Recent Developments
Table 110. Bio-Rad Laboratories Corporation Information
Table 111. Bio-Rad Laboratories Description and Major Businesses
Table 112. Bio-Rad Laboratories Product Models, Descriptions and Specifications
Table 113. Bio-Rad Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Bio-Rad Laboratories Recent Developments
Table 115. Horiba Corporation Information
Table 116. Horiba Description and Major Businesses
Table 117. Horiba Product Models, Descriptions and Specifications
Table 118. Horiba Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Horiba Recent Developments
Table 120. Thermo Fisher Scientific Corporation Information
Table 121. Thermo Fisher Scientific Description and Major Businesses
Table 122. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 123. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Thermo Fisher Scientific Recent Developments
Table 125. bioMerieux Corporation Information
Table 126. bioMerieux Description and Major Businesses
Table 127. bioMerieux Product Models, Descriptions and Specifications
Table 128. bioMerieux Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. bioMerieux Recent Developments
Table 130. Danaher Corporation Information
Table 131. Danaher Description and Major Businesses
Table 132. Danaher Product Models, Descriptions and Specifications
Table 133. Danaher Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Danaher Recent Developments
Table 135. Abbott Corporation Information
Table 136. Abbott Description and Major Businesses
Table 137. Abbott Product Models, Descriptions and Specifications
Table 138. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Abbott Recent Developments
Table 140. BD Corporation Information
Table 141. BD Description and Major Businesses
Table 142. BD Product Models, Descriptions and Specifications
Table 143. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. BD Recent Developments
Table 145. Mindray Corporation Information
Table 146. Mindray Description and Major Businesses
Table 147. Mindray Product Models, Descriptions and Specifications
Table 148. Mindray Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Mindray Recent Developments
Table 150. Key Raw Materials Distribution
Table 151. Raw Materials Key Suppliers
Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 153. Milestones in Production Technology Evolution
Table 154. Distributors List
Table 155. Market Trends and Market Evolution
Table 156. Market Drivers and Opportunities
Table 157. Market Challenges, Risks, and Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources


List of Figures
Figure 1. Nucleic Acid Blood Screening Product Picture
Figure 2. Global Nucleic Acid Blood Screening Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Blood Screening Equipment Product Picture
Figure 4. blood Screening Reagents Product Picture
Figure 5. Global Nucleic Acid Blood Screening Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Blood Center
Figure 7. Central Blood Station
Figure 8. Central Blood Bank
Figure 9. Nucleic Acid Blood Screening Report Years Considered
Figure 10. Global Nucleic Acid Blood Screening Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 12. Global Nucleic Acid Blood Screening Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Nucleic Acid Blood Screening Revenue Market Share by Region (2020-2031)
Figure 14. Global Nucleic Acid Blood Screening Sales (2020-2031) & (K Units)
Figure 15. Global Nucleic Acid Blood Screening Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Nucleic Acid Blood Screening Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Nucleic Acid Blood Screening Sales Volume Market Share in 2024
Figure 18. Global Nucleic Acid Blood Screening Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Blood Screening Equipment Revenue Market Share by Manufacturer in 2024
Figure 21. blood Screening Reagents Revenue Market Share by Manufacturer in 2024
Figure 22. Global Nucleic Acid Blood Screening Sales Market Share by Type (2020-2031)
Figure 23. Global Nucleic Acid Blood Screening Revenue Market Share by Type (2020-2031)
Figure 24. Global Nucleic Acid Blood Screening Sales Market Share by Application (2020-2031)
Figure 25. Global Nucleic Acid Blood Screening Revenue Market Share by Application (2020-2031)
Figure 26. North America Nucleic Acid Blood Screening Sales YoY (2020-2031) & (K Units)
Figure 27. North America Nucleic Acid Blood Screening Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Nucleic Acid Blood Screening Sales Revenue (US$ Million) in 2024
Figure 29. North America Nucleic Acid Blood Screening Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Nucleic Acid Blood Screening Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Nucleic Acid Blood Screening Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Nucleic Acid Blood Screening Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Nucleic Acid Blood Screening Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Nucleic Acid Blood Screening Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Nucleic Acid Blood Screening Sales Revenue (US$ Million) in 2024
Figure 39. Europe Nucleic Acid Blood Screening Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Nucleic Acid Blood Screening Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Nucleic Acid Blood Screening Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Nucleic Acid Blood Screening Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 44. France Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Nucleic Acid Blood Screening Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Nucleic Acid Blood Screening Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Nucleic Acid Blood Screening Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Nucleic Acid Blood Screening Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Nucleic Acid Blood Screening Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Nucleic Acid Blood Screening Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Nucleic Acid Blood Screening Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 59. India Nucleic Acid Blood Screening Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Nucleic Acid Blood Screening Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Nucleic Acid Blood Screening Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Nucleic Acid Blood Screening Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Nucleic Acid Blood Screening Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Nucleic Acid Blood Screening Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Nucleic Acid Blood Screening Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Nucleic Acid Blood Screening Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Nucleic Acid Blood Screening Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Nucleic Acid Blood Screening Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Nucleic Acid Blood Screening Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Nucleic Acid Blood Screening Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Nucleic Acid Blood Screening Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Nucleic Acid Blood Screening Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Nucleic Acid Blood Screening Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Nucleic Acid Blood Screening Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Nucleic Acid Blood Screening Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Nucleic Acid Blood Screening Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Nucleic Acid Blood Screening Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Nucleic Acid Blood Screening Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Nucleic Acid Blood Screening Revenue (2020-2025) & (US$ Million)
Figure 80. Nucleic Acid Blood Screening Industry Chain Mapping
Figure 81. Regional Nucleic Acid Blood Screening Manufacturing Base Distribution (%)
Figure 82. Global Nucleic Acid Blood Screening Production Market Share by Region (2020-2031)
Figure 83. Nucleic Acid Blood Screening Production Process
Figure 84. Regional Nucleic Acid Blood Screening Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit